✦ LIBER ✦

A placebo-controlled screening trial of olanzapine, valproate, and coenzyme Q10/L-carnitine for the treatment of cocaine dependence

✍ Scribed by Malcolm S. Reid; Paul Casadonte; Sherryl Baker; Michael Sanfilipo; Dania Braunstein; Robert Hitzemann; Ann Montgomery; Dorota Majewska; James Robinson; John Rotrosen

Book ID: 108597222
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 214 KB
Volume: 100
Category: Article
ISSN: 0965-2140
DOI: 10.1111/j.1360-0443.2005.00990.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A placebo-controlled screening trial of

A placebo-controlled screening trial of celecoxib for the treatment of cocaine dependence

✍ Malcolm S. Reid; Burt Angrist; Sherryl Baker; Caroline Woo; Marion Schwartz; Ann 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Cocaine Rapid Efficacy Screening Trial (

Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence

✍ Deborah B. Leiderman; Steve Shoptaw; Ann Montgomery; Daniel A. Bloch; Ahmed Elka 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Employment-based abstinence reinforcemen

Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: a randomized controlled trial

✍ Anthony DeFulio; Wendy D. Donlin; Conrad J. Wong; Kenneth Silverman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

A randomized, placebo-controlled trial o

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

✍ Nicolino Ruperto; Daniel J. Lovell; Ruben Cuttica; Nick Wilkinson; Patricia Woo; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract ## Objective To evaluate the safety and efficacy of infliximab in the treatment of juvenile rheumatoid arthritis (JRA). ## Methods This was an international, multicenter, randomized, placebo‐controlled, double‐blind study. One hundred twenty‐two children with persistent polyarticular

Combination therapy with thymosin α1 and

Combination therapy with thymosin α1 and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo-controlled double-blind trial

✍ Kenneth E. Sherman; Maria Sjogren; Robin L. Creager; Melissa A. Damiano; Stephen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

Hepatitis C is a major cause of liver disease leading to cirrhosis. Although interferon (IFN) is the only approved therapy, treatment is characterized by low response rates and dose-limiting side effects. We evaluated the addition of thymosin ␣1 (TA1), an immunomodulatory peptide, to the standard tr

A placebo-controlled double blind trial

A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome : Results from N00C1 from the North Central Cancer Treatment Group

✍ Aminah Jatoi; Shaker R. Dakhil; Phuong L. Nguyen; Jeff A. Sloan; John W. Kugler; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract ## BACKGROUND. Tumor necrosis factor‐α (TNF‐α) is a putative mediator of the cancer anorexia/weight loss syndrome. The current study was designed to determine whether etanercept (a dimeric fusion protein consisting of the extracellular ligand‐binding portion of the human 75‐kilodalton